Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-κB signaling pathway in isoproterenol-induced myocardial hypertrophy

被引:102
|
作者
Yang, Juan [1 ,2 ]
Wang, Hong-Xin [1 ]
Zhang, Ying-Jie [2 ]
Yang, Yu-Hong [1 ]
Lu, Mei-Li [1 ]
Zhang, Jing [1 ]
Li, Sheng-Tao [1 ]
Zhang, Su-Ping [1 ]
Li, Guang [3 ]
机构
[1] Liaoning Med Coll, Inst Drug Res, Key Lab Cardiovasc & Cerebrovasc Drug Res Liaonin, Jinzhou 121001, Peoples R China
[2] Liaoning Med Coll, Affiliated Hosp 1, Jinzhou 121001, Peoples R China
[3] Liaoning Med Coll, Affiliated Hosp 5, Orthoped Surgeon Dept Cent Hosp Jinzhou City, Jinzhou 121001, Peoples R China
基金
中国国家自然科学基金;
关键词
Astragaloside IV; Isoproterenol; Myocardial hypertrophy; Inflammatory effect; TLR4/NF-kappa B; INDUCED CARDIAC-HYPERTROPHY; NF-KAPPA-B; VENTRICULAR MYOCYTES; EXPRESSION; RECEPTOR; RATS; ISOPRENALINE; ALPHA;
D O I
10.1016/j.jep.2013.10.017
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Astragaloside IV (As IV) is one of the main effective components isolated from the traditional Chinese medical herb Astragalus membranaceus. The protective effect of Astragalus membranaceus on myocardial hypertrophy has been extensively proved. To test the hypothesis that Astragaloside IV can ameliorate the myocardial hypertrophy and inflammatory effect induced by beta-adrenergic hyperactivity, we carried out in vivo and in vitro experiments. Material and methods: In in vivo study, the isoproterenol (Iso) (5 mg kg(-1) d(-1)) was used as a model of myocardial hypertrophy by intraperitoneal injection. SD rats were randomly assigned to following six groups: A: the control; B: Iso group; C: Iso plus As IV 20 mg kg(-1) d(-1); D: Iso plus As IV 40 mg kg(-1) d(-1); E: Iso plus As IV 80 mg kg(-1) d(-1); F: Iso plus Propranolol 40 mg kg(-1) d(-1). In in vitro study, cultured neonatal rat cardiomyocytes were pretreated with As IV (3, 10, 30 mu mol L-1), Propranolol (2 mu mol L-1) and BAY11-7082 (5 mu mol L-1) for 30 min, and then incubated with Iso (10 mu mol L-1) for 48 h. For the rats in each group, the heart mass index (HMI) and the left ventricular mass index (LVMI) were measured. To measure the transverse diameter of left ventricular myocardial cells (TDM), the hematoxylin-eosin (HE) staining method was applied. In addition, the volume and the total protein content of cardiomyocytes were measured, the mRNA expression of ANP and TLR4 were quantified by RT-PCR, the protein expression of TLR4, I kappa B alpha and p65 were quantified by Western blot, and the level of TNF-alpha and IL-6 were measured by ELISA. Results: In vivo: Comparing the Iso group to the control, the HML LVMI, TDM were significantly increased; the protein expression of TLR4 and p65 were increased, while the I kappa B alpha were decreased; the expression of ANP, TLR4 mRNA, and TNF-alpha, IL-6 in serum were significantly increased. These changes could be partly prevented by As IV and Pro. In vitro: the over-expression of the cell size, total protein content could remarkably down-regulated by As N and Pro, and the results of RT-PCR, Western blot and ELISA were similar to those of in vivo. Conclusions: The results of these studies indicate that Astragaloside IV has good protective effect on myocardial hypertrophy induced by isoproterenol. More specifically, the cardioprotection is related to inhibiting the TLR4/NF-kappa B signaling pathway and the attenuating inflammatory effect. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1062 / 1070
页数:9
相关论文
共 50 条
  • [1] Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice
    Nalban, Nasiruddin
    Sangaraju, Rajendra
    Alavala, Sateesh
    Mir, Salma Mukhtar
    Jerald, Mahesh Kumar
    Sistla, Ramakrishna
    CARDIOVASCULAR TOXICOLOGY, 2020, 20 (03) : 235 - 248
  • [2] Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice
    Nasiruddin Nalban
    Rajendra Sangaraju
    Sateesh Alavala
    Salma Mukhtar Mir
    Mahesh Kumar Jerald
    Ramakrishna Sistla
    Cardiovascular Toxicology, 2020, 20 : 235 - 248
  • [3] Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway
    Leng, Bin
    Tang, Futian
    Lu, Meili
    Zhang, Zhen
    Wang, Hongxin
    Zhang, Yingjie
    LIFE SCIENCES, 2018, 209 : 111 - 121
  • [4] Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway
    Shi, Hui
    Zhou, Peng
    Gao, Ge
    Liu, Pei-pei
    Wang, Shu-shu
    Song, Rui
    Zou, Ying-ying
    Yin, Gang
    Wang, Liang
    JOURNAL OF FOOD BIOCHEMISTRY, 2021, 45 (07)
  • [5] Inhibition of Mogroside IIIE on isoproterenol-induced myocardial fibrosis through the TLR4/MyD88/NF-ΚB signaling pathway
    Shi, Yanan
    Li, Bohan
    Sun, Shuaifeng
    Tian, Wendan
    Ma, Zizhe
    Wei, Liu
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (01) : 114 - 120
  • [6] Astragaloside IV exerts anti-inflammatory role in endometriosis by downregulating TLR4/NF-κB pathway
    Zhang, Yongping
    Huang, Ouping
    Zhang, Wei
    Liu, Luxin
    Xu, Caiwei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (03) : 539 - 545
  • [7] Astragaloside protects myocardial cells from apoptosis through suppression of the TLR4/NF-κB signaling pathway
    Zhao, Yang
    Liu, Zhongfen
    Zhang, Hu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1505 - 1509
  • [8] MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway
    He, Fengping
    Liu, Yanhui
    Li, Tang
    Ma, Qiulin
    Yongmei, Zhang
    He, Peiqing
    Xiong, Chuanyin
    BIOENGINEERED, 2022, 13 (05) : 11611 - 11623
  • [9] Lycium ruthenicum polysaccharide attenuates inflammation through inhibiting TLR4/NF-κB signaling pathway
    Peng, Qiang
    Liu, Huajing
    Shi, Shihui
    Li, Ming
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 67 : 330 - 335
  • [10] Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice
    Ma, Donglai
    Zhang, Jianping
    Zhang, Yuanyuan
    Zhang, Xuan
    Han, Xue
    Song, Tao
    Zhang, Ying
    Chu, Li
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 55 : 237 - 244